• Register
  • Login
  • Subscribe
  • Contact Us

Latest Medicinal Product Tenders in Czech Republic 2026

CzechRepublicTenders brings you the latest and most relevant Medicinal Product tenders in Czech Republic, sourced directly from reliable government portals, purchaser websites, and leading procurement publications. Whether you're a supplier, contractor, or manufacturer, we ensure you stay informed about ongoing bidding opportunities without missing a beat.

Our platform is regularly updated with tenders related to Medicinal Product and other keywords tenders. Each listing includes key details such as tender reference numbers, submission deadlines, and purchaser information helping you make informed bidding decisions quickly and confidently.

By subscribing to CzechRepublicTenders, users gain unlimited access to public procurement notices related to Medicinal Product. Our tools also offer category-based filtering, email alerts, and quick tender downloads, making your bidding process faster and more efficient. Stay ahead of the competition and grow your business by exploring verified tenders from both government and private entities across Czech Republic.

Joint Nutrition 2025

CZT Ref No.:  127801690

Deadline:  12 Nov 2025

Delivery of a Medicinal Product - Remdesivir

CZT Ref No.:  127801587

Deadline:  16 Oct 2025

Monoclonal Antibody - Dupilumab I.

CZT Ref No.:  127801525

Deadline:  11 Nov 2025

Drug Supply - Erenumab - Atc N02cd01 Active Substance

CZT Ref No.:  127735292

Deadline:  07 Nov 2025

Drug Supply - the Active Substance Nirsevimab - Atc J06bd08

CZT Ref No.:  127734943

Deadline:  07 Nov 2025

Drug Supply - Nusinersen - Atc M09ax07

CZT Ref No.:  127732422

Deadline:  07 Nov 2025

Drug Supply - the Active Substance Abatacept - Atc L04aa24

CZT Ref No.:  127727120

Deadline:  07 Nov 2025

Drug Supply - the Active Substance Yomeprol - Atc V08ab10

CZT Ref No.:  127726126

Deadline:  07 Nov 2025

Lp to Treat Pulmonary Arterial Hypertension (Pah) Xiv.

CZT Ref No.:  127722316

Deadline:  07 Nov 2025

  Chat with us